Hangzhou-based, transcatheter heart valve company Venus Medtech has raised HK$1.2bn (US$153m) in a placement in Hong Kong. The 18.5 million shares priced at the top of the HK$62.88-HK$64.19 range which…
Hangzhou-based, transcatheter heart valve company Venus Medtech has raised HK$1.2bn (US$153m) in a placement in Hong Kong. The 18.5 million shares priced at the top of the HK$62.88-HK$64.19 range which…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference